Archives
-
Rotenone Workflows for Mitochondrial Stress Research
2026-09-14
Use Rotenone as a controlled mitochondrial Complex I inhibitor to connect energy failure, mitochondrial ROS, and regulated cell death in cardiomyocyte and neuronal models. This practical workflow emphasizes dose finding, orthogonal readouts, and a literature-grounded strategy for testing whether NLRP3 signaling depends on mitochondrial stress.
-
Maternal Deltamethrin Exposure, Ferroptosis, and Memory
2026-09-13
The reference study links maternal deltamethrin exposure with impaired hippocampal learning and memory in male offspring through a p53-associated ferroptosis pathway. Its combination of developmental exposure, behavioral testing, hippocampal pathology, biochemical profiling, and HT-22 cell experiments provides a useful framework for studying how environmental toxicants connect p53 signaling, redox failure, and calcium homeostasis.
-
EdU Cell Proliferation Kit: Signal to Decision
2026-09-12
The EdU Cell Proliferation Kit (TMB) converts nascent DNA synthesis into a practical S-phase readout for mechanistic and translational studies. This guide explains how to interpret EdU signals in ARL4C-driven rheumatoid arthritis research without confusing proliferation with invasion, apoptosis, or macrophage polarization.
-
Biomimetic mRNA Nanovaccines Target Neutrophils
2026-09-11
A 2026 study developed CD300LD-targeted, cell-membrane-coated liposomes carrying mRNA encoding albumin-fused IL-36γ to activate tumor-associated neutrophils in hepatocellular carcinoma. The approach reframes neutrophils as therapeutically reprogrammable immune effectors and provides a rationale for combining receptor-guided delivery with cytokine mRNA engineering.
-
Epigenetic Immune Signatures in Melanoma
2026-09-11
Anichini et al. compared how distinct epigenetic drug classes reshape immune-related transcriptional programs in melanoma and identified guadecitabine, a DNA methyltransferase inhibitor, as the most consistent inducer of innate immune signatures. The study links cell-line profiling with patient biopsies, xenograft analysis, upstream-regulator modeling, and TCGA-based prognosis to clarify which epigenetic perturbations may best complement immune checkpoint blockade.
-
GANT61 Targets the Hh–PIK3IP1–Akt Axis in ALK+ ALCL
2026-09-10
A 2026 study identifies GANT61 as an inhibitor of ALK-positive anaplastic large cell lymphoma cell growth and links its pro-apoptotic activity to Gli1 suppression, PIK3IP1 restoration, and reduced Akt phosphorylation. The work provides a mechanistic framework for studying Hedgehog–PI3K/Akt crosstalk while also highlighting the need for genetic and in vivo validation.
-
Stat3 in Fyn-Driven Dopaminergic Neurodegeneration
2026-09-10
A 2024 zebrafish study identifies Stat3 as a downstream effector linking constitutively active Fyn kinase to dopaminergic neuron loss, mitochondrial abnormalities, and microglial inflammation. Its combination of neural-specific genetics, live imaging, transcriptomics, and pathway inhibition provides a mechanistic framework for studying neurodegeneration and for designing carefully bounded functional gene studies.
-
Cytarabine (AraC) Workflows for Apoptosis Research
2026-09-09
Cytarabine (AraC) provides a controllable way to connect DNA synthesis blockade with apoptosis, resistance biology, and leukemia model design. This workflow-focused guide shows how to optimize dosing, distinguish pathway effects from nonspecific toxicity, and use viral necroptosis research to sharpen—not overstate—mechanistic interpretation.
-
N3-kethoxal: Reading Structure Before Damage
2026-09-09
N3-kethoxal converts exposed guanine bases in RNA and single-stranded DNA into clickable molecular records. This guide explains how to interpret those signals alongside R-loop biology, distinguish accessibility from damage, and design more defensible structural assays.
-
Reactive Oxygen Species Assay Kit (DHE) Guide
2026-09-08
The Reactive Oxygen Species Assay Kit uses a dihydroethidium (DHE) probe to assess intracellular superoxide-related fluorescence in living cells. K2066 supports oxidative stress assay workflows, but red fluorescence should be interpreted with appropriate controls because DHE signal is not an absolute measurement of total ROS.
-
BIRC2 and BIRC3 Regulation in Pulmonary Epithelium
2026-09-08
The reference study distinguishes how inflammatory cytokines and glucocorticoids regulate the related inhibitor-of-apoptosis proteins BIRC2 and BIRC3 in pulmonary epithelial models. Its findings support a model in which constitutive BIRC2 favors rapid signaling capacity, whereas inducible BIRC3 may provide later and glucocorticoid-supported protection during airway inflammation.
-
Protease Inhibitor Cocktail for Lipid Droplet Assays
2026-09-07
Protect DFCP1, ATGL, and interaction partners during starvation, lipid droplet, and metabolic-stress workflows with a broad-spectrum, water-soluble inhibitor mixture. This guide translates the DFCP1–ATGL mechanism into practical extraction, co-immunoprecipitation, Western blot, and purification decisions while addressing EDTA compatibility.
-
Tc3 Pyroptosis and Combination Therapy in Hepatic Carcinoma
2026-09-07
The reference study identifies Tc3, a thiazolidinedione-substituted indole analogue, as a hepatic carcinoma growth inhibitor that promotes PRDX1-linked oxidative stress, endoplasmic reticulum stress, and GSDME-mediated pyroptosis. Its combination with cisplatin or anti-PD-1 therapy produced stronger antitumor activity in experimental models, while GSDME expression emerged as a potential response-associated biomarker.
-
BCA Protein Quantification Kit K4102 Guide
2026-09-05
The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit K4102 provides total-protein measurement for dilute samples, including many detergent-containing biochemical preparations and cell lysates. It is intended for scientific research workflows such as sample normalization and is not for diagnostic, clinical, or medical testing.
-
Busulfan Assays: Separating Injury from Regeneration
2026-09-04
Busulfan is a DNA alkylating agent with applications in senescence and germ-cell depletion models. This guide focuses on the deeper assay question: how dual-recombinase lineage tracing distinguishes tissue injury from genuine postnatal oocyte regeneration.